Robert Hamilton Pierce - Aug 6, 2021 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Chief Scientific Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
Aug 6, 2021
Transactions value $
-$568,246
Form type
4
Date filed
8/10/2021, 05:40 PM
Previous filing
Aug 10, 2021
Next filing
Aug 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Sale -$45.9K -6.46K -6.74% $7.11* 89.4K Aug 6, 2021 By spouse F1, F2
transaction SNSE Common Stock Sale -$49.3K -6.98K -7.81% $7.06* 82.4K Aug 9, 2021 By spouse F2, F3
transaction SNSE Common Stock Sale -$473K -66.4K -80.54% $7.13* 16K Aug 10, 2021 By spouse F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.04 to $7.20, inclusive. The reporting person undertakes to provide to Sensei Biotherapeutics, Inc., any security holder of Sensei Biotherapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4.
F2 The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.10, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.42, inclusive.